(R)-1-[1-(4-Acetoxy-3,3-dimethyl-2-oxo-butyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-3-(3-methylamino-phenyl)-urea | |
---|---|
Trade Name | |
Orphan Indication | Gastric neuroendocrine tumors (gastric NETs) |
USA Market Approval | USA |
USA Designation Date | 2016-05-12 00:00:00 |
Sponsor | Trio Medicines Ltd.;Pavillion View, Brighton BN1 1EY; |